DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA)

CAPS Rating: No stars

A dermatology company, which is engaged in the development and marketing Levulan photodynamic therapy and other products for common skin conditions.

Results 1 - 1 of 1


Member Avatar cibient (< 20) Submitted: 10/26/2010 10:53:35 AM : Outperform Start Price: $2.45 DUSA Score: +152.65

Pharm micro-cap with a good balance sheet and real revenues with a few established products (primary one is Levulan Kerastick).


Results 1 - 1 of 1

Featured Broker Partners